EXHIBIT  2

                           MINUTES OF A MEETING OF THE
             BOARD OF DIRECTORS OF HUBEI PHARMACEUTICAL GROUP, LTD.
                        HELD ON THE 30TH DAY OF MAY, 2003


The  following  resolutions  were  passed  by  the  Board  of Directors of Hubei
Pharmaceutical  Group,  Ltd.  (the  "Corporation")  having been consented to and
adopted  in  writing  by  all the Directors of the Company as at May 30th, 2003.

WHEREAS,  the  undersigned  are Directors of Hubei Pharmaceutical Group, Ltd., a
Nevada company, and they desire to take the action hereinafter set forth without
a  duly  called  meeting  of  the  Directors.

NOW  THEREFORE  the  undersigned  hereby  adopts the following resolution, which
shall  have  the same force and effect as if adopted at a duly called meeting of
the  Directors:

RESOLVED  THAT:

     2.   The  Corporation  accept  the  private placement subscription offer to
          subscribe  for 80,000 units at a price of $0.15 each consisting of one
          share  of  common  stock  and  2.5  purchase  warrants  to purchase an
          additional  share  of  common  stock  at  a  price  of  $0.20 with the
          aggregate  total of 200,000 purchase warrants to expire November 30th,
          2003  if  not  exercised.  These  shares will be issued in reliance on
          exemptions  from  registration  under  the  Securities Act of 1933, as
          amended. As a result, all shares of the Company issued with respect to
          the  private  placement  are subject to restrictions on transfer under
          the  applicable  provisions  of  the  securities  act and will carry a
          legend  reflecting  such  restrictions.

     3.   The  Corporation  accept  the  private  placement  subscription offers
          tendered  by  a group of accredited investors to subscribe for a total
          of  2,366,324  units consisting of a single share of common stock at a
          price  of  $0.15  each.  These  shares  will  be issued in reliance on
          exemptions  from  registration  under  the  Securities Act of 1933, as
          amended. As a result, all shares of the Company issued with respect to
          the  private  placements are subject to restrictions on transfer under
          the  applicable  provisions  of  the  securities  act and will carry a
          legend  reflecting  such  restrictions.

EFFECTIVE this 30th day of May, 2003.



/s/  Reid  Li                                 /s/  Clint  Cheng
- ----------------------------------            --------------------------------
Reid  Li,  President                          Cling  Cheng,  Director


/s/  Eric  Fletcher
- ----------------------------------
Eric  Fletcher,  Secretary